GRAIL, Inc. cotiza a 132.61 USD y tiene una capitalización bursátil de $5.9B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-1.34 | $-1.37 | $-2.44 |
| Estimado | $-1.90 | $-2.43 | $-1.96 | $-2.53 |
| Sorpresa | — | +44.9% | +30.1% | +3.6% |
| Métrica | GRAL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -382.0% | -38.6% | -343.4% |
| Net Margin | -277.5% | -33.6% | -243.9% |
| FCF Margin | -203.8% | -13.9% | -189.9% |
| ROE | -15.8% | -40.4% | +24.6% |
| ROA | -14.0% | -32.0% | +18.0% |
| Current Ratio | 11.97 | 2.84 | +9.13 |
| Debt / Equity | — | 0.28 | — |